Methotrexate Tablet Manufacturer & Wholesaler Supplier

Methotrexate is a medication available in different strengths, including Methotrexate 2.5 mg, Methotrexate 5 mg, Methotrexate 7.5 mg, and Methotrexate 10 mg tablets. It contains the active ingredient Methotrexate, which belongs to a class of drugs known as antimetabolites. Psorwin tablets are primarily used in the treatment of psoriasis, psoriatic arthritis, pustular psoriasis, psoriatic erythroderma, and Sezary syndrome. It is available in a pack containing 10×10 tablets.

Glasierwellness is a leading manufacturer and wholesale supplier of Methotrexate Tablet in India

Psorwin 2.5 Tablet: Each tablet contains Methotrexate 2.5 mg. Methotrexate is an antimetabolite and immunosuppressant medication. It works by interfering with the production of DNA and inhibiting the rapid growth of cells, including the overactive skin cells in psoriasis. Methotrexate also modulates the immune response, reducing inflammation and suppressing the immune system’s attack on healthy cells.

Psorwin 5 Tablet: Each tablet contains Methotrexate 5 mg. This strength provides a slightly higher dosage of Methotrexate, which may be required for individuals with more severe psoriasis or those who have not responded adequately to lower doses.

Psorwin 7.5 Tablet: Each tablet contains Methotrexate 7.5 mg. This dosage offers a further increase in Methotrexate concentration, suitable for individuals with more extensive or resistant psoriasis lesions or psoriatic arthritis.

Psorwin 10 Tablet: Each tablet contains Methotrexate 10 mg. This strength provides the highest dosage of Methotrexate available in the Psorwin range. It is used in severe cases of psoriasis or psoriatic arthritis that require a more intensive treatment approach.

Methotrexate, the active ingredient in Psorwin tablets, is a folic acid antagonist that blocks the action of dihydrofolate reductase, an enzyme essential for the synthesis of DNA and RNA. By inhibiting this enzyme, Methotrexate disrupts the rapid division of cells, including the abnormal skin cells characteristic of psoriasis. It also interferes with the production of inflammatory substances, such as cytokines, reducing inflammation and immune system activity.

Methotrexate has been widely studied and proven effective in the treatment of psoriasis and psoriatic arthritis. It helps reduce the symptoms of psoriasis, such as redness, scaling, itching, and plaque formation. In the case of psoriatic arthritis, Methotrexate can alleviate joint pain, swelling, and stiffness, improving overall joint function.

Psoriasis: Psorwin tablets are indicated for the treatment of psoriasis, a chronic autoimmune skin condition characterized by red, scaly patches on the skin. Psoriasis occurs when the immune system mistakenly attacks healthy skin cells, causing them to multiply rapidly and accumulate on the surface of the skin. Methotrexate, the active ingredient in Psorwin tablets, helps suppress the immune system, reduce inflammation, and slow down the excessive growth of skin cells. It is effective in managing various forms of psoriasis, including plaque psoriasis, guttate psoriasis, inverse psoriasis, and psoriasis affecting the scalp, nails, or joints.

Psoriatic Arthritis: Psorwin tablets are also indicated for the treatment of psoriatic arthritis, a type of arthritis that affects some individuals with psoriasis. Psoriatic arthritis causes joint pain, swelling, and stiffness, often accompanied by skin symptoms. Methotrexate helps reduce joint inflammation, alleviate pain, and improve joint function in individuals with psoriatic arthritis. It works by suppressing the immune system and targeting the underlying inflammatory processes involved in the disease.

Pustular Psoriasis: Psorwin tablets are specifically indicated for the treatment of pustular psoriasis, a rare and severe form of psoriasis characterized by the presence of pus-filled blisters on the skin. Pustular psoriasis can be localized or generalized, and it often requires systemic treatment to control the inflammation and prevent further complications. Methotrexate in Psorwin tablets helps regulate the immune response and reduce the severity of pustular psoriasis, promoting healing and improving the overall condition of the skin.

Psoriatic Erythroderma: Psorwin tablets are indicated for the treatment of psoriatic erythroderma, a rare but severe form of psoriasis that affects the entire body surface area. Psoriatic erythroderma is characterized by widespread redness, scaling, and shedding of the skin. It can cause significant discomfort, pain, and disruption of the body’s normal temperature regulation. Methotrexate in Psorwin tablets helps control the inflammation and rapid cell turnover associated with psoriatic erythroderma, providing relief and promoting the healing of the skin.

Sezary Syndrome: Psorwin tablets are also indicated for the treatment of Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma characterized by widespread skin involvement, lymph node enlargement, and abnormal T-cells in the blood. Methotrexate, with its immunosuppressive properties, can help manage the symptoms of Sezary syndrome and improve the overall condition of the skin. It works by targeting the abnormal T-cells and reducing their proliferation, thus controlling the disease progression.

Reduces Inflammation: Methotrexate in Psorwin tablets has anti-inflammatory properties that help reduce the redness, swelling, and itching associated with psoriasis, psoriatic arthritis, pustular psoriasis, and psoriatic erythroderma.

Suppresses Immune Response:  Methotrexate tablets modulate the immune system, preventing it from attacking healthy skin cells and reducing the overactive immune response observed in autoimmune conditions like psoriasis.

Controls Skin Cell Growth: Methotrexate in Psorwin tablets slows down the rapid proliferation of skin cells, which is a key factor in the development of psoriatic plaques. It helps normalize the growth and shedding of skin cells, improving the appearance and reducing the thickness of psoriatic lesions.

Alleviates Itching and Discomfort: By reducing inflammation and controlling the underlying immune response, Methotrexate tablets help alleviate itching and discomfort associated with psoriasis and related conditions.

Improves Joint Symptoms: For individuals with psoriatic arthritis, Methotrexate tablets can help reduce joint inflammation, swelling, and pain, improving mobility and overall joint function.

Manages Severe Forms of Psoriasis:  Methotrexate tablets are specifically indicated for severe forms of psoriasis, such as pustular psoriasis and psoriatic erythroderma. They provide systemic treatment to address widespread inflammation and control the symptoms associated with these conditions.

Supports Disease Remission: With proper use and under medical supervision, Methotrexate tablets can help achieve and maintain periods of remission, where psoriasis symptoms are significantly reduced or even disappear.

Enhances Quality of Life: By effectively managing the symptoms of psoriasis and related conditions, Methotrexate tablets contribute to improved quality of life, allowing individuals to engage in daily activities without the limitations imposed by their skin or joint symptoms.

Reduces Flare-ups: Consistent use of Methotrexate tablets can help reduce the frequency and severity of psoriasis flare-ups, minimizing the impact of the condition on daily life.

Treats Scalp Psoriasis:  Methotrexate tablets can address scalp psoriasis, a common manifestation of the condition, by targeting the underlying immune response and reducing scalp inflammation and scaling.

Controls Nail Psoriasis: Nail psoriasis, which causes changes in the appearance and texture of fingernails and toenails, can be effectively managed with Psorwin tablets, improving the overall health and appearance of the nails.

Delays Disease Progression:  Methotrexate tablets, when used as prescribed, can slow down the progression of psoriasis and related conditions, preventing further damage to the skin, joints, and other affected areas.

Provides Long-lasting Relief: The systemic action of Methotrexate tablets provides long-lasting relief from psoriasis symptoms, allowing individuals to experience extended periods of improved skin and joint health.

Effective in Combination Therapy:  Methotrexate tablets can be used in combination with other psoriasis treatments, such as topical medications or phototherapy, to enhance the overall effectiveness and achieve better control of the condition.

Reduces Systemic Inflammation: In addition to its effects on the skin and joints, Methotrexate in Psorwin tablets also helps reduce systemic inflammation, benefiting overall health and well-being.

Targets Resistant Psoriasis:  Methotrexate tablets are particularly useful in cases of psoriasis that have not responded adequately to other treatments, providing an alternative option for individuals with treatment-resistant forms of the condition.

Supports Long-term Disease Management:  Methotrexate tablets can be used as part of a long-term treatment plan to manage chronic psoriasis, helping individuals maintain control over their symptoms and prevent disease exacerbations.

Promotes Self-confidence and Mental Well-being: By improving the physical appearance of the skin and relieving symptoms, Methotrexate tablets contribute to increased self-confidence and enhanced mental well-being, reducing the psychological impact of psoriasis.

Tailored Dosage Options:  Methotrexate tablets are available in different strengths, allowing healthcare professionals to tailor the dosage according to the severity of the condition and the individual’s response to treatment.

Monitored Treatment: The use of Methotrexate tablets typically involves regular monitoring and follow-up with a healthcare professional to assess the effectiveness of the treatment, monitor for any potential side effects, and make necessary adjustments to the dosage or treatment plan.

dualized Treatment Approach: The treatment with Methotrexate tablets is personalized to each patient, taking into consideration their specific condition, medical history, and other factors to ensure optimal outcomes.

Well-Established Efficacy: Methotrexate, the active ingredient in Psorwin tablets, has been extensively studied and proven effective in the management of psoriasis and related conditions, providing confidence in its therapeutic benefits.

Clinically Proven Results: Numerous clinical trials and studies have demonstrated the efficacy of Methotrexate in improving the signs and symptoms of psoriasis, supporting its use in the treatment of the condition.

Safe and Well-Tolerated: When used as directed and under medical supervision, Methotrexate tablets are generally safe and well-tolerated. However, individual responses may vary, and it is important to be aware of potential side effects and communicate any concerns to a healthcare professional.

Treatment Continuity:  Methotrexate tablets support the continuity of treatment, ensuring that individuals have access to reliable and effective therapy for the long-term management of their psoriasis and related conditions.

Expert Medical Guidance: The use of Methotrexate tablets should always be guided by a qualified healthcare professional experienced in the treatment of psoriasis. They can provide the necessary expertise and guidance to ensure the safe and effective use of the medication.

Patient Education and Support: Healthcare professionals, along with the patient information on the pack, can educate and support individuals in understanding the treatment goals, potential side effects, and necessary precautions associated with Methotrexate tablets.

Regular Monitoring: Regular check-ups and monitoring of blood tests may be required during the course of Methotrexate tablet treatment to evaluate the response to therapy, assess liver function, and monitor for any potential adverse effects.

Compliance and Adherence: Adhering to the prescribed dosage and treatment regimen with Methotrexate tablets is crucial for optimal outcomes. It is important to follow the healthcare professional’s instructions carefully and communicate any difficulties or concerns regarding the medication.

• Methotrexate tablets should be taken exactly as prescribed by a healthcare professional. Follow the instructions provided on the packaging or as directed by your doctor.
• The tablets are typically taken orally with water. Swallow the tablet whole, without crushing or chewing it.
• The dosage and frequency of administration will depend on the specific condition being treated, the severity of the symptoms, and individual patient factors. Always adhere to the prescribed dosage and do not exceed or decrease the recommended dose without consulting your doctor.
• It is important to take Methotrexate tablets consistently at the same time each day to maintain a steady level of the medication in your body. This helps optimize the effectiveness of the treatment.
• Methotrexate tablets may be taken with or without food, as advised by your healthcare professional. However, if you experience stomach upset or gastrointestinal discomfort, taking the tablets with food may help alleviate these symptoms.
• Do not abruptly stop taking Methotrexate tablets without consulting your doctor, as this may lead to a worsening of symptoms or a flare-up of the underlying condition. If you have concerns about continuing the treatment, discuss them with your healthcare provider.

• Store Methotrexate tablets in their original packaging to protect them from moisture and light.
• Keep the tablets at room temperature, away from excessive heat or cold, and in a dry place. Avoid storing them in the bathroom or near sources of moisture.
• Keep Methotrexate tablets out of reach and sight of children and pets, as they are not intended for use by anyone other than the prescribed individual.
• Do not use Methotrexate tablets beyond the expiration date mentioned on the packaging. Discard any expired or unused tablets properly, following the local guidelines for medication disposal.

• Methotrexate tablets should only be used under the guidance and supervision of a qualified healthcare professional experienced in the treatment of psoriasis, psoriatic arthritis, pustular psoriasis, psoriatic erythroderma, or Sezary syndrome.
• Inform your doctor about any pre-existing medical conditions, allergies, or medications you are currently taking before starting treatment with Methotrexate tablets.
• Methotrexate tablets may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), retinoids, and other immunosuppressant drugs. Inform your doctor or pharmacist about all the medications you are taking to prevent any potential interactions.
• Avoid drinking alcohol excessively while on Methotrexate tablet treatment, as it may increase the risk of liver toxicity associated with Methotrexate.
• It is important to undergo regular monitoring, including blood tests while taking Psorwin tablets to assess liver function, kidney function, and blood cell counts. Follow your doctor’s recommendations for monitoring and adhere to the scheduled appointments.
• Women of childbearing potential should use effective contraception during treatment with Psorwin tablets and for a certain period after discontinuation, as Methotrexate may cause birth defects. Consult your doctor for suitable contraceptive methods and recommendations.
• If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits of Methotrexate tablet treatment with your doctor. Methotrexate may not be suitable during pregnancy or while breastfeeding.
• In case of any unexpected side effects, worsening of symptoms, or concerns about the treatment, promptly contact your healthcare provider for further evaluation and guidance.

The information provided here is for informational purposes only and is not intended to replace or substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider or physician with any questions you may have regarding a medical condition or the use of any medication.

The content provided regarding the product Methotrexate 2.5 / 5 / 7.5 / 10 mg Tablet is based on general knowledge and understanding of the subject matter up to the date of this response. However, medical knowledge is constantly evolving, and new research may emerge that could impact the understanding or recommendations related to this product.

The use of Methotrexate tablets should be guided by a qualified healthcare professional who can assess your specific medical condition, consider individual factors, and make appropriate treatment decisions. Every individual is unique, and the response to treatment may vary. Therefore, the information provided here should not be considered a guarantee of specific results or outcomes.

It is crucial to carefully read and follow the patient information leaflet provided inside the pack of Methotrexate tablets. This leaflet contains important instructions, precautions, and possible side effects associated with the use of the product. Failure to adhere to the instructions or neglecting to seek medical advice may result in ineffective treatment or adverse effects.

The use of Methotrexate tablets may have associated risks, which should be thoroughly discussed with a healthcare professional. These risks may include but are not limited to liver toxicity, gastrointestinal disturbances, bone marrow suppression, lung complications, and potential interactions with other medications. Regular monitoring, such as blood tests and medical check-ups, may be necessary to ensure safe and effective use of the product.

Individuals with specific medical conditions, such as liver disease, kidney disease, immunodeficiency, or pregnancy, may require special precautions or considerations when using Methotrexate tablets. It is important to disclose your complete medical history and provide accurate information to your healthcare provider to ensure appropriate evaluation and personalized treatment.

The information provided here is not exhaustive and may not include all possible interactions, precautions, warnings, or adverse effects associated with Methotrexate tablets. Therefore, it is essential to consult your healthcare provider or pharmacist for comprehensive and up-to-date information specific to your condition.

The manufacturer, distributor, and suppliers of Methotrexate tablets do not assume any liability or responsibility for any direct, indirect, incidental, consequential, or other damages arising from the use of the product or the information provided herein.

Methotrexate tablets should only be used under the supervision and guidance of a qualified healthcare professional. The information provided here is not a substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult a healthcare professional for personalized advice, taking into account your individual medical condition, history, and treatment requirements.